CompletedNot applicableNCT05182775

A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanxi Provincial People's Hospital
Principal Investigator
Ya-feng Li, Professor
Shanxi Medical University
Intervention
Fecal bacteria transplantation(procedure)
Enrollment
15 enrolled
Eligibility
18-70 years · All sexes
Timeline
2022 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05182775 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy →

← Back to all trials